• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
1AI 0.00% 1.1¢

ALGORAE PHARMACEUTICALS LIMITED - Announcements

Algorae Pharmaceuticals Limited, formerly Living Cell Technologies Limited, is an... Algorae Pharmaceuticals Limited, formerly Living Cell Technologies Limited, is an Australia-based pharmaceutical development company. The Company is focused on discovering and developing novel treatments for medical conditions with under met medical needs. Its programs include AlgoraeOS, Dementia and Parkinson’s. Its drug candidates include NTCELL for Parkinson’s disease and the AI-116 combination drug candidate for dementia. AlgoraeOS is a closed-loop platform, leveraging advanced computational tools to generate novel insights in-silico that are being developed to initiate or accelerate therapeutic programs. The AI-116 is a novel combination drug candidate made up of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. The NTCELL is an alginate coated capsule product containing clusters of neonatal porcine choroid plexus cells that are injected into the damaged site within the brain to target the treatment of Parkinson’s disease.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


1AI NTCELL Parkinsons trial patient data at 18 monthsPRICE SENSITIVE02/11/18 download Created with Sketch. 517.25KB
1AI Appendix 4C - quarterlyPRICE SENSITIVE26/10/18 download Created with Sketch. 378.19KB
1AI Response to ASX Price QueryPRICE SENSITIVE19/10/18 download Created with Sketch. 425.5KB
1AI Annual Report to shareholders15/10/18 download Created with Sketch. 1.2MB
1AI Notice of Annual General Meeting/Proxy Form15/10/18 download Created with Sketch. 452.36KB
1AI Change of Director's Interest Notice - R Elliott05/09/18 download Created with Sketch. 128.95KB
1AI Appendix 3X - K Taylor31/08/18 download Created with Sketch. 589.7KB
1AI Appendix 3Z - R Austin31/08/18 download Created with Sketch. 340.72KB
1AI LCT Board Changes31/08/18 download Created with Sketch. 682.87KB
1AI Company Secretary Appointment30/08/18 download Created with Sketch. 283.51KB
1AI Updated Securities Trading Policy30/08/18 download Created with Sketch. 146.02KB
1AI Appendix 4G and Corporate Governance Statement30/08/18 download Created with Sketch. 512.12KB
1AI Preliminary Final Report and 2018 Financial StatementsPRICE SENSITIVE30/08/18 download Created with Sketch. 693.96KB
1AI Living Insights Newsletter August 201813/08/18 download Created with Sketch. 142.74KB
1AI Appendix 4C - quarterlyPRICE SENSITIVE26/07/18 download Created with Sketch. 287.56KB
1AI Ceasing to be a substantial holder16/05/18 download Created with Sketch. 100.22KB
1AI NTCELL and Parkinsons trial updatePRICE SENSITIVE15/05/18 download Created with Sketch. 213.1KB
1AI Appendix 4C - quarterlyPRICE SENSITIVE26/04/18 download Created with Sketch. 870.32KB
1AI LCT Strategy UpdatePRICE SENSITIVE11/04/18 download Created with Sketch. 308.42KB
1AI Half Yearly Report and Accounts22/02/18 download Created with Sketch. 1.72MB
1AI LCT to sell JV Shares and receive DIABECELL licencePRICE SENSITIVE25/01/18 download Created with Sketch. 90.47KB
1AI Appendix 4C - QuarterlyPRICE SENSITIVE24/01/18 download Created with Sketch. 339.43KB
1AI NTCELL and Parkinson's Clinical Trial Update21/12/17 download Created with Sketch. 146.14KB
1AI Results of Annual General Meeting15/11/17 download Created with Sketch. 575.93KB
1AI Change in substantial holding13/11/17 download Created with Sketch. 154.03KB
1AI Results of LCT Parkinsons trial require further analysisPRICE SENSITIVE10/11/17 download Created with Sketch. 666.88KB
1AI Trading HaltPRICE SENSITIVE09/11/17 download Created with Sketch. 108.08KB
1AI LCT files pericyte protective agent provisional patentPRICE SENSITIVE07/11/17 download Created with Sketch. 484.63KB
1AI Cleansing Statement27/10/17 download Created with Sketch. 298.01KB
1AI Appendix 3B27/10/17 download Created with Sketch. 763.21KB
1AI Appendix 4C Quarterly Cash Flow Report 30 September 2017PRICE SENSITIVE18/10/17 download Created with Sketch. 687.03KB
1AI Annual Report to shareholders16/10/17 download Created with Sketch. 3.69MB
1AI Notice of Annual General Meeting/Proxy Form16/10/17 download Created with Sketch. 489.29KB
1AI Cleansing Statement10/10/17 download Created with Sketch. 298.32KB
1AI Appendix 3B10/10/17 download Created with Sketch. 763.2KB
1AI Cleansing Statement04/10/17 download Created with Sketch. 407.82KB
1AI Appendix 3B04/10/17 download Created with Sketch. 523.33KB
1AI Response to ASX Price QueryPRICE SENSITIVE03/10/17 download Created with Sketch. 165.66KB
1AI Cleansing Statement22/09/17 download Created with Sketch. 298KB
1AI Appendix 3B22/09/17 download Created with Sketch. 441.31KB
1AI Cleansing Statement19/09/17 download Created with Sketch. 298.38KB
1AI Appendix 3B19/09/17 download Created with Sketch. 763.25KB
1AI Appendix 4G and Corporate Governance Statement29/08/17 download Created with Sketch. 757.17KB
1AI Preliminary Final Report and Financial StatementsPRICE SENSITIVE23/08/17 download Created with Sketch. 1.38MB
1AI Living Insights Newsletter July 201724/07/17 download Created with Sketch. 535.7KB
1AI Appendix 4C - quarterlyPRICE SENSITIVE20/07/17 download Created with Sketch. 778.18KB
1AI Cleansing Statement30/06/17 download Created with Sketch. 298.49KB
1AI Appendix 3B30/06/17 download Created with Sketch. 763KB
1AI NTCELL continues to halt progression of Parkinson's diseasePRICE SENSITIVE06/06/17 download Created with Sketch. 511.33KB
1AI LCT collaborates with CBR to extend product pipelinePRICE SENSITIVE16/05/17 download Created with Sketch. 459.88KB
1AI Treatment completed for all patients in Parkinsons trialPRICE SENSITIVE01/05/17 download Created with Sketch. 467.06KB
1AI Appendix 4C - quarterlyPRICE SENSITIVE26/04/17 download Created with Sketch. 776.78KB
1AI Amended Change of Director's Interest Notice14/03/17 download Created with Sketch. 251.27KB
1AI Change of Director's Interest Notice13/03/17 download Created with Sketch. 270.84KB
1AI CEO Presentation - Halting Parkinsons with cell therapy28/02/17 download Created with Sketch. 1.09MB
1AI Living Insights Newsletter February 2017PRICE SENSITIVE28/02/17 download Created with Sketch. 707.53KB
1AI Half Yearly Report and AccountsPRICE SENSITIVE22/02/17 download Created with Sketch. 719.89KB
1AI Approval granted for group 3 in Parkinsons trialPRICE SENSITIVE08/02/17 download Created with Sketch. 332.69KB
1AI Appendix 4C - quarterlyPRICE SENSITIVE20/01/17 download Created with Sketch. 650.09KB
1AI US choroid plexus cells patent application publishedPRICE SENSITIVE11/01/17 download Created with Sketch. 88.79KB
1AI Group 2 Parkinsons trial patients treatment completedPRICE SENSITIVE22/12/16 download Created with Sketch. 88.22KB
1AI Corporate Governance Statement21/12/16 download Created with Sketch. 383.11KB
1AI Amended Appendix 3B21/12/16 download Created with Sketch. 703.25KB
1AI Ceasing to be a substantial holder14/12/16 download Created with Sketch. 864.98KB
1AI Becoming a substantial holder07/12/16 download Created with Sketch. 147.29KB
1AI Cleansing Statement06/12/16 download Created with Sketch. 290.14KB
1AI Appendix 3B06/12/16 download Created with Sketch. 757.6KB
1AI Living Insights Newsletter01/12/16 download Created with Sketch. 522.93KB
1AI Reinstatement to Official QuotationPRICE SENSITIVE30/11/16 download Created with Sketch. 232.05KB
1AI Private PlacementPRICE SENSITIVE30/11/16 download Created with Sketch. 437.34KB
1AI Suspension from Official QuotationPRICE SENSITIVE28/11/16 download Created with Sketch. 331.96KB
1AI Trading HaltPRICE SENSITIVE24/11/16 download Created with Sketch. 497.23KB
1AI Results of Annual General Meeting16/11/16 download Created with Sketch. 95.13KB
1AI Chairman and CEO Presentation to Annual General Meeting16/11/16 download Created with Sketch. 1.12MB
1AI Approval granted for group 2 in Parkinsons trialPRICE SENSITIVE11/11/16 download Created with Sketch. 333.64KB
1AI Appendix 4C Quarterly Cash Flow Report 30 September 2016-LCT.AX PRICE SENSITIVE20/10/16 download Created with Sketch. 623.51KB
1AI Notice of Annual General Meeting/Proxy Form-LCT.AX 17/10/16 download Created with Sketch. 490.44KB
1AI Annual Report to shareholders-LCT.AX 17/10/16 download Created with Sketch. 8.03MB
1AI Group 1 patients successfully treated in Parkinsons trial-LCT.AX PRICE SENSITIVE05/10/16 download Created with Sketch. 334.12KB
1AI 2016 Annual General Meeting and Director Nominations-LCT.AX 20/09/16 download Created with Sketch. 493.77KB
1AI Investor Presentation-LCT.AX 01/09/16 download Created with Sketch. 1.03MB
1AI Appendix 4G-LCT.AX 28/08/16 download Created with Sketch. 371.92KB
1AI Appendix 4G-LCT.AX 25/08/16 download Created with Sketch. 371.92KB
1AI Preliminary Final Report and Financial Statements-LCT.AX PRICE SENSITIVE24/08/16 download Created with Sketch. 1.8MB
1AI LCT's joint venture focuses on US developments-LCT.AX PRICE SENSITIVE22/08/16 download Created with Sketch. 321.01KB
1AI Response to ASX Price Query-LCT.AX PRICE SENSITIVE17/08/16 download Created with Sketch. 504.36KB
1AI Appendix 4C - quarterly-LCT.AX PRICE SENSITIVE28/07/16 download Created with Sketch. 589.86KB
1AI Living Insights Newsletter-LCT.AX 26/07/16 download Created with Sketch. 1.09MB
1AI NTCELL Trial Results to be Presented in Berlin-LCT.AX 23/06/16
1AI NTCELL Trial Results to be Presented in Berlin-LCT.AX 23/06/16 download Created with Sketch. 816.42KB
1AI Response to ASX Price Query-LCT.AX PRICE SENSITIVE22/06/16 download Created with Sketch. 249.63KB
1AI Appendix 3B-LCT.AX 08/06/16 download Created with Sketch. 319.95KB
1AI NTCELL demonstrates continued reversal of Parkinsons-LCT.AX PRICE SENSITIVE07/06/16 download Created with Sketch. 390.84KB
1AI Appendix 4G-LCT.AX 16/05/16 download Created with Sketch. 586.82KB
1AI Appendix 3B-LCT.AX 10/05/16 download Created with Sketch. 439.72KB
1AI Cleansing Statement-LCT.AX 21/04/16 download Created with Sketch. 146.47KB
1AI Appendix 3B-LCT.AX 21/04/16 download Created with Sketch. 536.29KB
1AI LCT successfully completes funding round-LCT.AX 21/04/16 download Created with Sketch. 315.71KB
1AI Appendix 4C - quarterly-LCT.AX PRICE SENSITIVE14/04/16 download Created with Sketch. 572.24KB
1AI Change in substantial holding-LCT.AX 08/04/16 download Created with Sketch. 176.88KB
1AI NTCELL Parkinsons trial patient data at 18 months
02/11/18PRICE SENSITIVE download Created with Sketch. 517.25KB
1AI Appendix 4C - quarterly
26/10/18PRICE SENSITIVE download Created with Sketch. 378.19KB
1AI Response to ASX Price Query
19/10/18PRICE SENSITIVE download Created with Sketch. 425.5KB
1AI Annual Report to shareholders
15/10/18 download Created with Sketch. 1.2MB
1AI Notice of Annual General Meeting/Proxy Form
15/10/18 download Created with Sketch. 452.36KB
1AI Change of Director's Interest Notice - R Elliott
05/09/18 download Created with Sketch. 128.95KB
1AI Appendix 3X - K Taylor
31/08/18 download Created with Sketch. 589.7KB
1AI Appendix 3Z - R Austin
31/08/18 download Created with Sketch. 340.72KB
1AI LCT Board Changes
31/08/18 download Created with Sketch. 682.87KB
1AI Company Secretary Appointment
30/08/18 download Created with Sketch. 283.51KB
1AI Updated Securities Trading Policy
30/08/18 download Created with Sketch. 146.02KB
1AI Appendix 4G and Corporate Governance Statement
30/08/18 download Created with Sketch. 512.12KB
1AI Preliminary Final Report and 2018 Financial Statements
30/08/18PRICE SENSITIVE download Created with Sketch. 693.96KB
1AI Living Insights Newsletter August 2018
13/08/18 download Created with Sketch. 142.74KB
1AI Appendix 4C - quarterly
26/07/18PRICE SENSITIVE download Created with Sketch. 287.56KB
1AI Ceasing to be a substantial holder
16/05/18 download Created with Sketch. 100.22KB
1AI NTCELL and Parkinsons trial update
15/05/18PRICE SENSITIVE download Created with Sketch. 213.1KB
1AI Appendix 4C - quarterly
26/04/18PRICE SENSITIVE download Created with Sketch. 870.32KB
1AI LCT Strategy Update
11/04/18PRICE SENSITIVE download Created with Sketch. 308.42KB
1AI Half Yearly Report and Accounts
22/02/18 download Created with Sketch. 1.72MB
1AI LCT to sell JV Shares and receive DIABECELL licence
25/01/18PRICE SENSITIVE download Created with Sketch. 90.47KB
1AI Appendix 4C - Quarterly
24/01/18PRICE SENSITIVE download Created with Sketch. 339.43KB
1AI NTCELL and Parkinson's Clinical Trial Update
21/12/17 download Created with Sketch. 146.14KB
1AI Results of Annual General Meeting
15/11/17 download Created with Sketch. 575.93KB
1AI Change in substantial holding
13/11/17 download Created with Sketch. 154.03KB
1AI Results of LCT Parkinsons trial require further analysis
10/11/17PRICE SENSITIVE download Created with Sketch. 666.88KB
1AI Trading Halt
09/11/17PRICE SENSITIVE download Created with Sketch. 108.08KB
1AI LCT files pericyte protective agent provisional patent
07/11/17PRICE SENSITIVE download Created with Sketch. 484.63KB
1AI Cleansing Statement
27/10/17 download Created with Sketch. 298.01KB
1AI Appendix 3B
27/10/17 download Created with Sketch. 763.21KB
1AI Appendix 4C Quarterly Cash Flow Report 30 September 2017
18/10/17PRICE SENSITIVE download Created with Sketch. 687.03KB
1AI Annual Report to shareholders
16/10/17 download Created with Sketch. 3.69MB
1AI Notice of Annual General Meeting/Proxy Form
16/10/17 download Created with Sketch. 489.29KB
1AI Cleansing Statement
10/10/17 download Created with Sketch. 298.32KB
1AI Appendix 3B
10/10/17 download Created with Sketch. 763.2KB
1AI Cleansing Statement
04/10/17 download Created with Sketch. 407.82KB
1AI Appendix 3B
04/10/17 download Created with Sketch. 523.33KB
1AI Response to ASX Price Query
03/10/17PRICE SENSITIVE download Created with Sketch. 165.66KB
1AI Cleansing Statement
22/09/17 download Created with Sketch. 298KB
1AI Appendix 3B
22/09/17 download Created with Sketch. 441.31KB
1AI Cleansing Statement
19/09/17 download Created with Sketch. 298.38KB
1AI Appendix 3B
19/09/17 download Created with Sketch. 763.25KB
1AI Appendix 4G and Corporate Governance Statement
29/08/17 download Created with Sketch. 757.17KB
1AI Preliminary Final Report and Financial Statements
23/08/17PRICE SENSITIVE download Created with Sketch. 1.38MB
1AI Living Insights Newsletter July 2017
24/07/17 download Created with Sketch. 535.7KB
1AI Appendix 4C - quarterly
20/07/17PRICE SENSITIVE download Created with Sketch. 778.18KB
1AI Cleansing Statement
30/06/17 download Created with Sketch. 298.49KB
1AI Appendix 3B
30/06/17 download Created with Sketch. 763KB
1AI NTCELL continues to halt progression of Parkinson's disease
06/06/17PRICE SENSITIVE download Created with Sketch. 511.33KB
1AI LCT collaborates with CBR to extend product pipeline
16/05/17PRICE SENSITIVE download Created with Sketch. 459.88KB
1AI Treatment completed for all patients in Parkinsons trial
01/05/17PRICE SENSITIVE download Created with Sketch. 467.06KB
1AI Appendix 4C - quarterly
26/04/17PRICE SENSITIVE download Created with Sketch. 776.78KB
1AI Amended Change of Director's Interest Notice
14/03/17 download Created with Sketch. 251.27KB
1AI Change of Director's Interest Notice
13/03/17 download Created with Sketch. 270.84KB
1AI CEO Presentation - Halting Parkinsons with cell therapy
28/02/17 download Created with Sketch. 1.09MB
1AI Living Insights Newsletter February 2017
28/02/17PRICE SENSITIVE download Created with Sketch. 707.53KB
1AI Half Yearly Report and Accounts
22/02/17PRICE SENSITIVE download Created with Sketch. 719.89KB
1AI Approval granted for group 3 in Parkinsons trial
08/02/17PRICE SENSITIVE download Created with Sketch. 332.69KB
1AI Appendix 4C - quarterly
20/01/17PRICE SENSITIVE download Created with Sketch. 650.09KB
1AI US choroid plexus cells patent application published
11/01/17PRICE SENSITIVE download Created with Sketch. 88.79KB
1AI Group 2 Parkinsons trial patients treatment completed
22/12/16PRICE SENSITIVE download Created with Sketch. 88.22KB
1AI Corporate Governance Statement
21/12/16 download Created with Sketch. 383.11KB
1AI Amended Appendix 3B
21/12/16 download Created with Sketch. 703.25KB
1AI Ceasing to be a substantial holder
14/12/16 download Created with Sketch. 864.98KB
1AI Becoming a substantial holder
07/12/16 download Created with Sketch. 147.29KB
1AI Cleansing Statement
06/12/16 download Created with Sketch. 290.14KB
1AI Appendix 3B
06/12/16 download Created with Sketch. 757.6KB
1AI Living Insights Newsletter
01/12/16 download Created with Sketch. 522.93KB
1AI Reinstatement to Official Quotation
30/11/16PRICE SENSITIVE download Created with Sketch. 232.05KB
1AI Private Placement
30/11/16PRICE SENSITIVE download Created with Sketch. 437.34KB
1AI Suspension from Official Quotation
28/11/16PRICE SENSITIVE download Created with Sketch. 331.96KB
1AI Trading Halt
24/11/16PRICE SENSITIVE download Created with Sketch. 497.23KB
1AI Results of Annual General Meeting
16/11/16 download Created with Sketch. 95.13KB
1AI Chairman and CEO Presentation to Annual General Meeting
16/11/16 download Created with Sketch. 1.12MB
1AI Approval granted for group 2 in Parkinsons trial
11/11/16PRICE SENSITIVE download Created with Sketch. 333.64KB
1AI Appendix 4C Quarterly Cash Flow Report 30 September 2016-LCT.AX
20/10/16PRICE SENSITIVE download Created with Sketch. 623.51KB
1AI Notice of Annual General Meeting/Proxy Form-LCT.AX
17/10/16 download Created with Sketch. 490.44KB
1AI Annual Report to shareholders-LCT.AX
17/10/16 download Created with Sketch. 8.03MB
1AI Group 1 patients successfully treated in Parkinsons trial-LCT.AX
05/10/16PRICE SENSITIVE download Created with Sketch. 334.12KB
1AI 2016 Annual General Meeting and Director Nominations-LCT.AX
20/09/16 download Created with Sketch. 493.77KB
1AI Investor Presentation-LCT.AX
01/09/16 download Created with Sketch. 1.03MB
1AI Appendix 4G-LCT.AX
28/08/16 download Created with Sketch. 371.92KB
1AI Appendix 4G-LCT.AX
25/08/16 download Created with Sketch. 371.92KB
1AI Preliminary Final Report and Financial Statements-LCT.AX
24/08/16PRICE SENSITIVE download Created with Sketch. 1.8MB
1AI LCT's joint venture focuses on US developments-LCT.AX
22/08/16PRICE SENSITIVE download Created with Sketch. 321.01KB
1AI Response to ASX Price Query-LCT.AX
17/08/16PRICE SENSITIVE download Created with Sketch. 504.36KB
1AI Appendix 4C - quarterly-LCT.AX
28/07/16PRICE SENSITIVE download Created with Sketch. 589.86KB
1AI Living Insights Newsletter-LCT.AX
26/07/16 download Created with Sketch. 1.09MB
1AI NTCELL Trial Results to be Presented in Berlin-LCT.AX
23/06/16
1AI NTCELL Trial Results to be Presented in Berlin-LCT.AX
23/06/16 download Created with Sketch. 816.42KB
1AI Response to ASX Price Query-LCT.AX
22/06/16PRICE SENSITIVE download Created with Sketch. 249.63KB
1AI Appendix 3B-LCT.AX
08/06/16 download Created with Sketch. 319.95KB
1AI NTCELL demonstrates continued reversal of Parkinsons-LCT.AX
07/06/16PRICE SENSITIVE download Created with Sketch. 390.84KB
1AI Appendix 4G-LCT.AX
16/05/16 download Created with Sketch. 586.82KB
1AI Appendix 3B-LCT.AX
10/05/16 download Created with Sketch. 439.72KB
1AI Cleansing Statement-LCT.AX
21/04/16 download Created with Sketch. 146.47KB
1AI Appendix 3B-LCT.AX
21/04/16 download Created with Sketch. 536.29KB
1AI LCT successfully completes funding round-LCT.AX
21/04/16 download Created with Sketch. 315.71KB
1AI Appendix 4C - quarterly-LCT.AX
14/04/16PRICE SENSITIVE download Created with Sketch. 572.24KB
1AI Change in substantial holding-LCT.AX
08/04/16 download Created with Sketch. 176.88KB
(20min delay)
Last
1.1¢
Change
0.000(0.00%)
Mkt cap ! $20.24M
Open High Low Value Volume
1.2¢ 1.2¢ 1.1¢ $117 10.41K

Buyers (Bids)

No. Vol. Price($)
6 1867185 1.1¢
 

Sellers (Offers)

Price($) Vol. No.
1.2¢ 1450643 6
View Market Depth
Last trade - 13.25pm 28/05/2024 (20 minute delay) ?
Last
1.1¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
1.1¢ 1.1¢ 1.1¢ 1000000
Last updated 13.25pm 28/05/2024 ?
1AI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.